SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001493152-17-006741
Filing Date
2017-06-16
Accepted
2017-06-16 16:00:26
Documents
5
Period of Report
2017-06-13
Items
Item 5.07: Submission of Matters to a Vote of Security Holders
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 form8-k.htm 8-K 43949
2 ex10-1.htm EX-10.1 54711
3 ex10-2.htm EX-10.2 57507
4 ex10-3.htm EX-10.3 67383
5 ex10-4.htm EX-10.4 64472
  Complete submission text file 0001493152-17-006741.txt   289377
Mailing Address 12264 EL CAMINO REAL SUITE 350 SAN DIEGO CA 92130
Business Address 12264 EL CAMINO REAL SUITE 350 SAN DIEGO CA 92130 858-704-4042
Imprimis Pharmaceuticals, Inc. (Filer) CIK: 0001360214 (see all company filings)

IRS No.: 450567010 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-35814 | Film No.: 17916057
SIC: 2834 Pharmaceutical Preparations